Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04925193 |
| Title | Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | University of Colorado, Denver |
| Indications | |
| Therapies |
Carfilzomib + Dexamethasone + Selinexor |
| Age Groups: | adult | senior |
| Covered Countries | USA |